Cai Chen-Leng, Molkentin Jeffery D
From the Department of Developmental and Regenerative Biology, and Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY (C.-L.C.); and Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center and Howard Hughes Medical Institute, OH (J.D.M.).
Circ Res. 2017 Jan 20;120(2):400-406. doi: 10.1161/CIRCRESAHA.116.309710.
The adult human heart is unable to regenerate after various forms of injury, suggesting that this organ lacks a biologically meaningful endogenous stem cell pool. However, injecting the infarcted area of the adult mammalian heart with exogenously prepared progenitor cells of various types has been reported to create new myocardium by the direct conversion of these progenitor cells into cardiomyocytes. These reports remain controversial because follow-up studies from independent laboratories failed to observe such an effect. Also, the exact nature of various putative myocyte-producing progenitor cells remains elusive and undefined across laboratories. By comparison, the field has gradually worked toward a consensus viewpoint that proposes that the adult mammalian myocardium can undergo a low level of new cardiomyocyte renewal of ≈1% per year, which is primarily because of proliferation of existing cardiomyocytes but not from the differentiation of putative progenitor cells. This review will weigh the emerging evidence, suggesting that the adult mammalian heart lacks a definable myocyte-generating progenitor cell of biological significance.
成年人类心脏在遭受各种形式的损伤后无法再生,这表明该器官缺乏具有生物学意义的内源性干细胞库。然而,据报道,向成年哺乳动物心脏的梗死区域注射外源性制备的各种类型祖细胞,可通过这些祖细胞直接转化为心肌细胞来生成新的心肌。这些报道仍存在争议,因为独立实验室的后续研究未能观察到这种效果。此外,各实验室对于各种假定的产生心肌细胞的祖细胞的确切性质仍难以捉摸且未明确界定。相比之下,该领域已逐渐形成一种共识观点,即成年哺乳动物心肌每年可进行约1%的低水平新心肌细胞更新,这主要是由于现有心肌细胞的增殖,而非假定祖细胞的分化。本综述将权衡新出现的证据,表明成年哺乳动物心脏缺乏具有生物学意义的可明确界定的产生心肌细胞的祖细胞。